Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats
文献类型：期刊论文
| 作者 | Wang, Yan-Ling1; Wang, Kang1; Yu, Shu-Jing1; Li, Qian1; Li, Na1; Lin, Peng-Yao1; Li, Ming-Ming1; Guo, Jian-You2
|
| 刊名 | GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
 |
| 出版日期 | 2015-03-01 |
| 卷号 | 253期号:3页码:389-398 |
| 关键词 | Diabetes Diabetic retinopathy Streptozotocin Toll-like receptor 4 TAK-242 |
| ISSN号 | 0721-832X |
| 英文摘要 | Diabetic retinopathy is severe damage to the retina caused by complications of diabetes, and is the prevailing cause of blindness. Accumulating evidence from both animal models and humans suggests that the inflammatory process plays a key role in the development of diabetic retinopathy and is facilitated by innate immune response. The aim of this study was to examine whether the TLR4 signaling pathway was involved in the streptozotocin-induced diabetic rat retina. |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000350510200008 |
| 源URL | [http://ir.psych.ac.cn/handle/311026/13496]  |
| 专题 | 心理研究所_中国科学院心理健康重点实验室 |
| 作者单位 | 1.Beijing Capital Med Univ, Affiliated Beijing Friendship Hosp, Dept Ophthalmol, Beijing 100050, Peoples R China 2.Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China |
| 推荐引用方式 GB/T 7714 | Wang, Yan-Ling,Wang, Kang,Yu, Shu-Jing,et al. Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats[J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY,2015,253(3):389-398. |
| APA | Wang, Yan-Ling.,Wang, Kang.,Yu, Shu-Jing.,Li, Qian.,Li, Na.,...&Guo, Jian-You.(2015).Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats.GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY,253(3),389-398. |
| MLA | Wang, Yan-Ling,et al."Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats".GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 253.3(2015):389-398. |
入库方式： OAI收割
来源：心理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。